Estudo randomizado | Efeito do tacrolimo vs. ciclofosfamida intravenosa na resposta parcial ou completa de pacientes com nefrite lúpica.

Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial – JAMA Network Open

Comentário no Twitter

In this RCT, oral tacrolimus was noninferior to intravenous cyclophosphamide for initial therapy of active lupus nephritis, with a more favorable safety profile. https://t.co/scz7lahVRU

— JAMA Network Open (@JAMANetworkOpen) March 30, 2022